Clinical Trials

367 enrolled 14 charts

Carcinoma, Renal Cell

NCT03200717 2023-08-21

IO-PAZ

62 enrolled 12 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01330966 2023-03-10

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma

47 enrolled 10 charts

Chondrosarcoma

NCT01759303 2021-04-13

Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung

Phase 2 Terminated

12 enrolled

Osteosarcoma

NCT01956669 2020-08-12

Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors

57 enrolled 22 charts

NCT02187302 2020-05-28

CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

115 enrolled

Carcinoma, Renal Cell

NCT00281632 2018-09-17

A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

35 enrolled 24 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00615524 2018-01-12

Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms, Neoplasm Metastasis

NCT00244764 2017-03-27

GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma

225 enrolled 10 charts

Carcinoma, Renal Cell

NCT00256880 2017-01-18

Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma

100 enrolled

GenitourinaryPlasma cell

Carcinoma, Renal Cell, Neoplasms, Plasma Cell

NCT02367651 2016-10-12

Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue Sarcoma

Phase 2 Withdrawn

NCT00347919 2016-02-25

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer

189 enrolled 15 charts

Breast Neoplasms, Neoplasm Metastasis

NCT00297258 2016-02-03

Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma

148 enrolled 8 charts

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial

NCT00430781 2015-05-08

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

228 enrolled 21 charts

Uterine Cervical Neoplasms, Neoplasms, Recurrence

NCT01227928 2015-03-03

Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women

145 enrolled 19 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00549328 2014-11-19

Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

Phase 2 Terminated

14 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung

NCT01313663 2014-10-27

A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population

Phase 2 Terminated

20 enrolled 21 charts

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT00849472 2014-03-04

Treatment With Pazopanib for Neoadjuvant Breast Cancer

101 enrolled 16 charts

Breast Neoplasms

NCT00871403 2013-06-20

Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer

107 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00350727 2013-04-19

VEG102857

75 enrolled 45 charts

CNS

Glioblastoma, Glioma, Recurrence

NCT00558103 2013-02-04

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer

163 enrolled 14 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00367679 2012-06-12

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

35 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung

NCT00561795 2012-03-22

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

12 enrolled 6 charts